Common use of anticholinergic medications in older patients with schizophrenia: findings of the Research on Asian Psychotropic Prescription Pattern (REAP) study, 2001-2009

International Journal of Geriatric Psychiatry
Yu-Tao XiangNaotaka Shinfuku

Abstract

This study surveyed the use of anticholinergic medications (ACMs) in older Asian patients with schizophrenia and examined its demographic and clinical correlates. A total of 1452 hospitalized patients with schizophrenia aged 55 years or older in nine Asian countries and territories were surveyed between 2001 and 2009. The cross-sectional data of patients' socio-demographic and clinical characteristics and the prescriptions of antipsychotic drugs and ACM were recorded using a standardized protocol and data collection procedure. The frequency of ACM prescription was 64.6% in the pooled sample, with 72.4%, 61.9%, and 59.5% in 2001, 2004, and 2009, respectively. Multiple logistic regression analysis of the whole sample revealed that patients on ACM had a higher dose of antipsychotic medications, and were more likely to have extrapyramidal side effects and receive first-generation antipsychotic medications. Anticholinergic medications were frequently used in older Asian patients with schizophrenia. Considering the potential side effects of ACM, the rationale for their widespread use in this patient population should be revisited.

References

Dec 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·C PerrisH Fröberg
Aug 1, 1991·Journal of Clinical Pharmacology·M R Lavin, A Rifkin
Nov 1, 1986·Acta Psychiatrica Scandinavica·R Vågen, K G Götestam
Nov 1, 1987·The American Journal of Psychiatry·R L BinderD E McNiel
Dec 31, 1997·Psychiatry and Clinical Neurosciences·G S UngvariT Leung
Feb 12, 1998·Journal of the American Academy of Child and Adolescent Psychiatry·J McClellan, J Werry
Feb 7, 1998·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J M KaneN R Schooler
Mar 31, 1998·The British Journal of Psychiatry : the Journal of Mental Science·M Knapp
Nov 7, 2000·PharmacoEconomics·E Lindström, K Bingefors
Mar 16, 2001·Journal of Psychiatric and Mental Health Nursing·R Gray, K Gournay
Oct 24, 2002·British Journal of Clinical Pharmacology·Gabor S UngvariHelen F K Chiu
Jun 26, 2003·The Journal of Clinical Psychiatry·Scott W Woods
Dec 18, 2003·Psychiatry and Clinical Neurosciences·Mian-Yoon ChongNaotaka Shinfuku
Jan 2, 2004·The American Journal of Psychiatry·Michael J MinzenbergSophia Vinogradov
Mar 23, 2004·Sleep Medicine·UNKNOWN U.S. Xyrem Multicenter Study Group
Apr 23, 2004·International Clinical Psychopharmacology·T DrimerY Barak
Jan 21, 2006·Acta Psychiatrica Scandinavica·R M CarnahanE A Chrischilles
May 26, 2007·Human Psychopharmacology
Nov 18, 2008·International Review of Psychiatry·Naotaka Shinfuku, Chay-Hoon Tan
Sep 19, 2009·Clinical Pharmacology and Therapeutics·H UchidaD C Mamo
Apr 3, 2010·Neuropsychiatric Disease and Treatment·Izchak KohenSum Lam
Dec 1, 2010·The Journal of Clinical Psychiatry·Barnett S Meyers, Dilip V Jeste
Feb 8, 2011·The International Journal of Neuropsychopharmacology·Phern-Chern TorRoss J Baldessarini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here